Back to search
FDAFDA · Food and drugs·Recall number D-0248-2025

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.

Published March 5, 2025 · Recall initiated: February 18, 2025

Summary

FDA records drug Class II recall D-0248-2025, published March 5, 2025 and initiated February 18, 2025. Recalling firm: Turbare Manufacturing; Status: Completed; Reported quantity: 1,147 syringes; Lot: Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: due to a quality control process deviation

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Turbare Manufacturing
Distributor
Nationwide in the USA
Lot
Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01. recalled?

Yes. FDA published recall D-0248-2025 on March 5, 2025. Reported hazard: Lack of Assurance of Sterility: due to a quality control process deviation

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail